Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The North Texas Uterine Fibroid Institute is a specialized medical facility based in Dallas, Texas, dedicated to the comprehensive diagnosis and treatment of uterine fibroids and adenomyosis. Operating as a specialized division of the Fertility Center of Dallas, the institute focuses on providing fertility-sparing treatment options for women who wish to avoid hysterectomy. Their clinical offerings include minimally invasive procedures such as Uterine Fibroid Embolization (UFE) and advanced surgical techniques like robotic-assisted myomectomy. The institute is led by reproductive endocrinologists who integrate gynecological care with reproductive medicine to optimize patient outcomes and preserve reproductive potential.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North Texas Uterine Fibroid Institute.